Outcomes Research in Cardiovascular Imaging: Report of a Workshop Sponsored by the National Heart, Lung, and Blood Institute

Pamela S. Douglas; Allen Taylor; Diane Bild; Robert Bonow; Philip Greenland; Michael Lauer; Frank Peacock; James Udelson

doi:10.1016/j.jcct.2009.06.001

Outcomes Research in Cardiovascular Imaging: Report of a Workshop Sponsored by the National Heart, Lung, and Blood Institute

Pamela S. Douglas^*, Allen Taylor, Diane Bild, Robert Bonow, Philip Greenland, Michael Lauer, Frank Peacock, James Udelson

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

6 Scopus citations

Abstract

In July of 2008, the National Heart, Lung, and Blood Institute convened experts in noninvasive cardiovascular imaging, outcomes research, statistics, and clinical trials to develop recommendations for future randomized controlled trials of the use of imaging in: 1) screening the asymptomatic patient for coronary artery disease; 2) assessment of patients with stable angina; 3) identification of acute coronary syndromes in the emergency room; and 4) assessment of heart failure patients with chronic coronary artery disease with reduced left ventricular ejection fraction. This study highlights several possible trial designs for each clinical situation.

Original language	English (US)
Pages (from-to)	212-223
Number of pages	12
Journal	Journal of cardiovascular computed tomography
Volume	3
Issue number	4
DOIs	https://doi.org/10.1016/j.jcct.2009.06.001
State	Published - Jul 2009

Funding

Dr. Taylor has received research grant support (without salary compensation) and educational honoraria from Abbott Labs for the topic of HDL cholesterol and prevention. Dr. Greenland served as a consultant to GE and Toshiba, and received a small honorarium from Pfizer for a role on a Visiting Professor Selection Committee. Dr. Peacock is on the Scientific Advisory Board, or is a consultant or speaker for Abbott, Beckman Coulter, Biosite, Heartscape, Inovise, Inverness, Ortho Clinical Diagnostics, and The Medicines Company. He has received research grants from Abbott, BAS, Biosite, Brahms, Heartscape, Inovise, Inverness, EKR, and The Medicines Company. Also, he has an ownership interest in Vital Sensors. Dr. Udelson is co-PI of the ROMICAT-2 trial, sponsored by the American College of Radiology Imaging Network (ACRIN). He has received research funding and has served as a consultant to Lantheus Medical Imaging and Molecular Insight Pharmaceuticals. Drs. Douglas and Taylor are co-first authors. Reviewers for this article are: Stephan Achenbach, MD, Associate Editor, JACC: Cardiovascular Imaging; Thomas Marwick, MBBS, PhD, Associate Editor, JACC: Cardiovascular Imaging; Christopher Kramer, MD, Associate Editor, JACC: Cardiovascular Imaging; Vasken Dilsizian, MD, Associate Editor, JACC: Cardiovascular Imaging.

Keywords

Cardiovascular imaging
Chest pain diagnosis
Clinical trials

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.jcct.2009.06.001

Cite this

@article{d65b591ec74b4e299cc10de1b68308fb,

title = "Outcomes Research in Cardiovascular Imaging: Report of a Workshop Sponsored by the National Heart, Lung, and Blood Institute",

abstract = "In July of 2008, the National Heart, Lung, and Blood Institute convened experts in noninvasive cardiovascular imaging, outcomes research, statistics, and clinical trials to develop recommendations for future randomized controlled trials of the use of imaging in: 1) screening the asymptomatic patient for coronary artery disease; 2) assessment of patients with stable angina; 3) identification of acute coronary syndromes in the emergency room; and 4) assessment of heart failure patients with chronic coronary artery disease with reduced left ventricular ejection fraction. This study highlights several possible trial designs for each clinical situation.",

keywords = "Cardiovascular imaging, Chest pain diagnosis, Clinical trials",

author = "Douglas, {Pamela S.} and Allen Taylor and Diane Bild and Robert Bonow and Philip Greenland and Michael Lauer and Frank Peacock and James Udelson",

note = "Funding Information: Dr. Taylor has received research grant support (without salary compensation) and educational honoraria from Abbott Labs for the topic of HDL cholesterol and prevention. Dr. Greenland served as a consultant to GE and Toshiba, and received a small honorarium from Pfizer for a role on a Visiting Professor Selection Committee. Dr. Peacock is on the Scientific Advisory Board, or is a consultant or speaker for Abbott, Beckman Coulter, Biosite, Heartscape, Inovise, Inverness, Ortho Clinical Diagnostics, and The Medicines Company. He has received research grants from Abbott, BAS, Biosite, Brahms, Heartscape, Inovise, Inverness, EKR, and The Medicines Company. Also, he has an ownership interest in Vital Sensors. Dr. Udelson is co-PI of the ROMICAT-2 trial, sponsored by the American College of Radiology Imaging Network (ACRIN). He has received research funding and has served as a consultant to Lantheus Medical Imaging and Molecular Insight Pharmaceuticals. Drs. Douglas and Taylor are co-first authors. Reviewers for this article are: Stephan Achenbach, MD, Associate Editor, JACC: Cardiovascular Imaging; Thomas Marwick, MBBS, PhD, Associate Editor, JACC: Cardiovascular Imaging; Christopher Kramer, MD, Associate Editor, JACC: Cardiovascular Imaging; Vasken Dilsizian, MD, Associate Editor, JACC: Cardiovascular Imaging. Copyright: Copyright 2009 Elsevier B.V., All rights reserved.",

year = "2009",

month = jul,

doi = "10.1016/j.jcct.2009.06.001",

language = "English (US)",

volume = "3",

pages = "212--223",

journal = "Journal of cardiovascular computed tomography",

issn = "1934-5925",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Outcomes Research in Cardiovascular Imaging

T2 - Report of a Workshop Sponsored by the National Heart, Lung, and Blood Institute

AU - Douglas, Pamela S.

AU - Taylor, Allen

AU - Bild, Diane

AU - Bonow, Robert

AU - Greenland, Philip

AU - Lauer, Michael

AU - Peacock, Frank

AU - Udelson, James

N1 - Funding Information: Dr. Taylor has received research grant support (without salary compensation) and educational honoraria from Abbott Labs for the topic of HDL cholesterol and prevention. Dr. Greenland served as a consultant to GE and Toshiba, and received a small honorarium from Pfizer for a role on a Visiting Professor Selection Committee. Dr. Peacock is on the Scientific Advisory Board, or is a consultant or speaker for Abbott, Beckman Coulter, Biosite, Heartscape, Inovise, Inverness, Ortho Clinical Diagnostics, and The Medicines Company. He has received research grants from Abbott, BAS, Biosite, Brahms, Heartscape, Inovise, Inverness, EKR, and The Medicines Company. Also, he has an ownership interest in Vital Sensors. Dr. Udelson is co-PI of the ROMICAT-2 trial, sponsored by the American College of Radiology Imaging Network (ACRIN). He has received research funding and has served as a consultant to Lantheus Medical Imaging and Molecular Insight Pharmaceuticals. Drs. Douglas and Taylor are co-first authors. Reviewers for this article are: Stephan Achenbach, MD, Associate Editor, JACC: Cardiovascular Imaging; Thomas Marwick, MBBS, PhD, Associate Editor, JACC: Cardiovascular Imaging; Christopher Kramer, MD, Associate Editor, JACC: Cardiovascular Imaging; Vasken Dilsizian, MD, Associate Editor, JACC: Cardiovascular Imaging. Copyright: Copyright 2009 Elsevier B.V., All rights reserved.

PY - 2009/7

Y1 - 2009/7

N2 - In July of 2008, the National Heart, Lung, and Blood Institute convened experts in noninvasive cardiovascular imaging, outcomes research, statistics, and clinical trials to develop recommendations for future randomized controlled trials of the use of imaging in: 1) screening the asymptomatic patient for coronary artery disease; 2) assessment of patients with stable angina; 3) identification of acute coronary syndromes in the emergency room; and 4) assessment of heart failure patients with chronic coronary artery disease with reduced left ventricular ejection fraction. This study highlights several possible trial designs for each clinical situation.

AB - In July of 2008, the National Heart, Lung, and Blood Institute convened experts in noninvasive cardiovascular imaging, outcomes research, statistics, and clinical trials to develop recommendations for future randomized controlled trials of the use of imaging in: 1) screening the asymptomatic patient for coronary artery disease; 2) assessment of patients with stable angina; 3) identification of acute coronary syndromes in the emergency room; and 4) assessment of heart failure patients with chronic coronary artery disease with reduced left ventricular ejection fraction. This study highlights several possible trial designs for each clinical situation.

KW - Cardiovascular imaging

KW - Chest pain diagnosis

KW - Clinical trials

UR - http://www.scopus.com/inward/record.url?scp=67649419265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649419265&partnerID=8YFLogxK

U2 - 10.1016/j.jcct.2009.06.001

DO - 10.1016/j.jcct.2009.06.001

M3 - Review article

C2 - 19577208

AN - SCOPUS:67649419265

SN - 1934-5925

VL - 3

SP - 212

EP - 223

JO - Journal of cardiovascular computed tomography

JF - Journal of cardiovascular computed tomography

IS - 4

ER -

Outcomes Research in Cardiovascular Imaging: Report of a Workshop Sponsored by the National Heart, Lung, and Blood Institute

Abstract

Funding

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this